SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-20-014378
Filing Date
2020-12-15
Accepted
2020-12-15 07:16:50
Documents
12
Period of Report
2020-12-15
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K acrs-20201215x8k.htm   iXBRL 8-K 39253
  Complete submission text file 0001558370-20-014378.txt   162555

Data Files

Seq Description Document Type Size
2 EX-101.SCH acrs-20201215.xsd EX-101.SCH 3041
3 EX-101.LAB acrs-20201215_lab.xml EX-101.LAB 16728
4 EX-101.PRE acrs-20201215_pre.xml EX-101.PRE 10782
5 EXTRACTED XBRL INSTANCE DOCUMENT acrs-20201215x8k_htm.xml XML 5078
Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37581 | Film No.: 201388208
SIC: 2834 Pharmaceutical Preparations